Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,189 | -38,837 | -34,336 | -28,636 | -4,208 |
| Depreciation Amortization | 103 | 19,480 | 19,380 | 19,282 | 95 |
| Other Working Capital | 1,740 | -2,712 | -2,116 | 1,354 | 25 |
| Other Operating Activity | 235 | 634 | 530 | 366 | 178 |
| Operating Cash Flow | $-3,111 | $-21,435 | $-16,542 | $-7,634 | $-3,910 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45 | -74 | -62 | N/A | N/A |
| Investing Cash Flow | $-45 | $-74 | $-62 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -7 | -27 | -20 | -13 | -6 |
| Financing Cash Flow | $-7 | $-27 | $-20 | $-13 | $-6 |
| Beginning Cash Position | 37,219 | 58,755 | 58,705 | 58,755 | 58,755 |
| End Cash Position | 34,056 | 37,219 | 42,131 | 51,108 | 54,839 |
| Net Cash Flow | $-3,163 | $-21,536 | $-16,624 | $-7,647 | $-3,916 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,111 | -21,435 | -16,542 | -7,634 | -3,910 |
| Capital Expenditure | -45 | -74 | -62 | N/A | N/A |
| Free Cash Flow | -3,156 | -21,509 | -16,604 | -7,634 | -3,910 |